Burgess MA - Search Results

1

Antibody persistence six years after two doses of combined hepatitis A and B vaccine.

Burgess MA, McIntyre PB, Hellard M, Ruff TA, Lefevre I, Bock HL. Burgess MA, et al. Vaccine. 2010 Mar 2;28(10):2222-2226. doi: 10.1016/j.vaccine.2009.12.053. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056187

2

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM. McIntyre PB, et al. Among authors: burgess ma. Vaccine. 2004 Dec 2;23(3):380-5. doi: 10.1016/j.vaccine.2004.05.030. Vaccine. 2004. PMID: 15530684 Clinical Trial.

3

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.

McIntyre PB, Burgess MA, Egan A, Schuerman L, Hoet B. McIntyre PB, et al. Among authors: burgess ma. Vaccine. 2009 Feb 11;27(7):1062-6. doi: 10.1016/j.vaccine.2008.11.102. Epub 2008 Dec 16. Vaccine. 2009. PMID: 19095033 Clinical Trial.

4

Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.

Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, MacIntyre CR. Gao Z, et al. Among authors: burgess ma. Vaccine. 2013 Jan 11;31(4):691-7. doi: 10.1016/j.vaccine.2012.11.043. Epub 2012 Nov 26. Vaccine. 2013. PMID: 23196206

5

PhD thesis opposing immunisation: Failure of academic rigour with real-world consequences.

Wiley KE, Leask J, Burgess MA, McIntyre PB. Wiley KE, et al. Among authors: burgess ma. Vaccine. 2019 Mar 14;37(12):1541-1545. doi: 10.1016/j.vaccine.2018.12.024. Vaccine. 2019. PMID: 30846059 Free article. No abstract available.

6

Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.

Burgess MA, Rodger AJ, Waite SA, Collard F. Burgess MA, et al. Vaccine. 2001 Sep 14;19(32):4835-41. doi: 10.1016/s0264-410x(01)00221-3. Vaccine. 2001. PMID: 11535336 Clinical Trial.

7

Hepatitis A vaccination options for Australia.

MacIntyre CR, Burgess MA, Hull B, McIntyre PB. MacIntyre CR, et al. Among authors: burgess ma. J Paediatr Child Health. 2003 Mar;39(2):83-7. doi: 10.1046/j.1440-1754.2003.00098.x. J Paediatr Child Health. 2003. PMID: 12603793 Review.

8

Women and vaccinations: From smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years.

Datta SK, Bhatla N, Burgess MA, Lehtinen M, Bock HL. Datta SK, et al. Among authors: burgess ma. Hum Vaccin. 2009 Jul;5(7):450-4. doi: 10.4161/hv.8805. Epub 2009 Jul 20. Hum Vaccin. 2009. PMID: 19458487 Free PMC article. Review.

9

Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model.

Cheuvart B, Burgess M, Zepp F, Mertsola J, Wolter J, Schuerman L. Cheuvart B, et al. Vaccine. 2004 Dec 2;23(3):336-42. doi: 10.1016/j.vaccine.2004.06.012. Vaccine. 2004. PMID: 15530678

10

Vaccine-associated paralytic poliomyelitis.

Burgess MA, McIntyre PB. Burgess MA, et al. Commun Dis Intell. 1999 Mar 18;23(3):80-1. Commun Dis Intell. 1999. PMID: 10323041 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page